Literature DB >> 8357789

Transmission of conformational change from the heparin binding site to the reactive center of antithrombin.

P G Gettins1, B Fan, B C Crews, I V Turko, S T Olson, V J Streusand.   

Abstract

Heparin greatly increases the rates at which antithrombin inhibits target proteinases. An important part of this rate acceleration is a heparin-induced conformational change in antithrombin. To answer the question of whether or not this change is transmitted to the reactive center, we have prepared a recombinant P1 mutant of antithrombin, R393C, labeled the cysteine with nitrobenzofuran (NBD) fluorophore, and examined the perturbation of NBD fluorescence intensity as a function of bound sulfated oligosaccharide. Two high-affinity heparins, low-affinity heparin, and dextran sulfate were used. We found (i) that binding to antithrombin of all these oligosaccharides resulted in transmission of conformational change to P1 in the reactive center, (ii) that these oligosaccharides all gave enhancements of the rate of inhibition of factor Xa beyond any contribution from surface approximation, and (iii) that the degree of perturbation of P1 correlated with the enhancement of the rate of factor Xa inhibition that was not due to surface approximation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8357789     DOI: 10.1021/bi00084a001

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  9 in total

1.  Role of Lys335 in the metastability and function of inhibitory serpins.

Authors:  H Im; M H Yu
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

Review 2.  Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated?

Authors:  R D Rosenberg; N W Shworak; J Liu; J J Schwartz; L Zhang
Journal:  J Clin Invest       Date:  1997-05-01       Impact factor: 14.808

Review 3.  Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance.

Authors:  Peter G W Gettins; Steven T Olson
Journal:  Biochem J       Date:  2016-08-01       Impact factor: 3.857

4.  The anticoagulant activation of antithrombin by heparin.

Authors:  L Jin; J P Abrahams; R Skinner; M Petitou; R N Pike; R W Carrell
Journal:  Proc Natl Acad Sci U S A       Date:  1997-12-23       Impact factor: 11.205

5.  Recombinant human pigment epithelium-derived factor (PEDF): characterization of PEDF overexpressed and secreted by eukaryotic cells.

Authors:  E Stratikos; E Alberdi; P G Gettins; S P Becerra
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

6.  Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition.

Authors:  Alireza R Rezaie; Chandrashekhara Manithody; Likui Yang
Journal:  J Biol Chem       Date:  2005-08-03       Impact factor: 5.157

Review 7.  Novel antithrombotic drugs in development.

Authors:  M Verstraete; P Zoldhelyi
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

8.  Heparin binding domain peptides of antithrombin III: analysis by isothermal titration calorimetry and circular dichroism spectroscopy.

Authors:  R Tyler-Cross; M Sobel; D Marques; R B Harris
Journal:  Protein Sci       Date:  1994-04       Impact factor: 6.725

9.  Bacteriophage Sf6 Tailspike Protein for Detection of Shigella flexneri Pathogens.

Authors:  Sonja Kunstmann; Tom Scheidt; Saskia Buchwald; Alexandra Helm; Laurence A Mulard; Angelika Fruth; Stefanie Barbirz
Journal:  Viruses       Date:  2018-08-15       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.